주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요

Elsevier
엘스비어와 함께 출판

ESMO Events 2025

Meetings | ESMO

Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.

ESMO Targeted Anticancer Therapies Asia Congress 2025

ESMO TAT, the multi-stakeholder forum gathering key actors in cancer drug development, arrives in one of the most dynamic and best-connected hubs in Asia, making the latest advances in early clinical trials accessible to everyone in the region. Through in-depth discussions on critical topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy, ESMO TAT Asia aims to drive progress in cancer treatment and research.

Located in the lively city of Hong Kong, ESMO TAT Asia promises to be a vibrant gathering with region’s industry, academia, clinicians, and regulators to promote international cooperation and accelerate the anticancer research.

Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.

Annals of Oncology

  • Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma R. Bartolini, L. Trueb, D. Daoudlarian, V. Joo, A. Noto, R. Stadelmann, B. Gentner, C. Fenwick, M. Perreau, G. Coukos, G. Pantaleo, C. Arber, M. Obeid

  • Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma P. Grover, S.N. Lo, I. Li, A.M.J. Kuijpers, F. Kreidieh, A. Williamson, T. Amaral, F. Dimitriou, J. Placzke, K. Olino, M.G. Vitale, P. Saiag, R. Gutzmer, C. Allayous, R. Olofsson Bagge, J. Mattsson, N. Asher, T.J. Carter, T.M. Meniawy, A.R. Lawless, J.A. Czapla, L. Warburton, C. Gaudy-Marqueste, J.J. Grob, R.G. Collins, E. Zhang, J.I. Kessels, B. Neyns, I. Mehmi, O. Hamid, M. Julve, A.J.S. Furness, K.A. Margolin, Shaked Lev-Ari, J.M. Ressler, W. Haque, M.A. Khattak, A. Wicky, R. Roberts-Thomson, A. Arance, G. Warrier, M.D. Schollenberger, P. Parente, E. Chatziioannou, E.J. Lipson, O. Michielin, J.S. Weber, C. Hoeller, J. Larkin, M.B. Atkins, R. Essner, D.B. Johnson, R.J. Sullivan, P. Nathan, J. Schachter, C. Lebbe, P.A. Ascierto, H. Kluger, P. Rutkowski, R. Dummer, C. Garbe, P.C. Lorigan, E. Burton, H.A. Tawbi, J. Haanen, M.S. Carlino, A.M. Menzies, G.V. Long

ESMO Open

Immuno-Oncology and Technology

ESMO Gastrointestinal Oncology

ESMO Real World Data and Digital Oncology

ESMO Rare Cancers

ESMO affiliated journals

ESMO's Journal Portfolio

While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.

ESMO - European Society for Medical Oncology journals